Early-Onset Parkinson's Disease: Unique Features and Management Approaches.
Level 5 - mechanism / opinion, no new human data
Narrative review without formal systematic review or meta-analysis methodology.
PubMed 41410819 · doi:10.1007/s11910-025-01470-2
What was done
This narrative review synthesized the clinical features, risk factors, progression patterns, and management considerations specific to early-onset Parkinson's disease (EOPD, onset age 21–50) compared to late-onset Parkinson's disease (LOPD).
What was found
The abstract provides no numerical data or effect estimates. Qualitatively, EOPD is characterized by higher rates of monogenic causes, focal dystonia, depression, anxiety, slower motor progression, lower cognitive decline rates, and higher risk of delayed diagnosis compared to LOPD. EOPD management is complicated by earlier and more frequent dyskinesias and motor fluctuations, as well as distinct psychosocial impacts regarding pregnancy and employment.
Why it matters
It emphasizes that management paradigms and trial designs developed for older populations fail to address the specific biological and life-stage needs of patients with early-onset Parkinson's disease.
Limits
The paper is a narrative review with no systematic search criteria, quality appraisal, or pooled quantitative metrics reported in the abstract. Sample sizes and details of primary studies are not provided.
Cited by
- supports Strong genetic contributions to Parkinson's disease are predominantly found in young-onset cases occurring under the age of 35.